http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#Head
http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#assertion
http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#provenance
http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#pubinfo
http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#assertion
http://purl.obolibrary.org/obo/DOID_409
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_409
http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB00819
http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#association
http://www.w3.org/2000/01/rdf-schema#label
"Acetazolamide therapy is contraindicated in situations in which sodium and/or potassium blood serum levels are depressed, in cases of marked kidney and liver disease or dysfunction, in suprarenal gland failure, and in hyperchloremic acidosis. It is contraindicated in patients with cirrhosis because of the risk of development of hepatic encephalopathy. Long-term administration of acetazolamide is contraindicated in patients with chronic non- congestive angle-closure glaucoma since it may permit organic closure of the angle to occur while the worsening glaucoma is masked by lowered intraocular pressure."
http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#association
https://w3id.org/biolink/vocab/relation
https://schema.org/MedicalContraindication
https://identifiers.org/drugbank:DB00819
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#provenance
http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#pubinfo
http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#sig
http://purl.org/nanopub/x/hasSignature
c+Cw6foEctJxHd8S+FdtAalLH+JhG55sjdwa7UfqlBjAXlXVnEs0aLPWmkYN+k2Y+wEcdPPCcYIPGid3+7RCc3tJWxrpuR+oQR5qSLiwcB9gkpuTryl7GAt0hZtqe16X8wvRP6F+au2T1mNeRpep8fuHQSxRoiJy0UgT2YvVAI8=
http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo
http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo
http://purl.org/dc/terms/created
2021-08-25T13:50:42.610+02:00
http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY